PMID: 6977500Jan 15, 1982Paper

Modulation of T leukaemic cell phenotype with phorbol ester

International Journal of Cancer. Journal International Du Cancer
D DeliaG Goldstein

Abstract

A panel of monoclonal antibodies and other markers (e.g., terminal deoxynucleotidyl transferase, sheep erythrocyte rosettes, peanut agglutinin) have been used in conjunction with flow cytometry and biochemical analysis to monitor the induction of maturation in human thymic (T) leukaemic cell lines by phorbol ester (TPA). Seven cell lines underwent multiple phenotypic alterations in response to TPA but were unresponsive to synthetic thymic hormones (TP5, FTS) or to other compounds (e.g. DMSO, retinoic acid) which induce maturation in other types of leukaemia. The changes parallel those observed in normal T-cell differentiation and partly reflect alterations in glycosyl transferase activity, altered synthesis of proteins and regulation of cell surface receptors (for transferrin) associated with rapid growth and metabolism. These studies further illustrate the reversibility of maturation arrest in human leukaemia and provide support for the view that leukaemia may involve regulatory defects in the coupling of proliferation and maturation. Induction of promotion of terminal differentiation in leukaemic equivalents of T-cell precursors may provide a convenient system for the study of biochemical and molecular events involved in T-ce...Continue Reading

References

Jan 1, 1979·Immunological Reviews·F M BrodskyW F Bodmer
Jun 1, 1978·Journal of the National Cancer Institute·J MinowadaE Tatsumi
Nov 17, 1978·Biochimica Et Biophysica Acta·T Graf, H Beug
May 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·S J CollinsR C Gallo
Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·G RoveraC Damsky
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·J Lotem, L Sachs
Oct 12, 1979·Biochemical and Biophysical Research Communications·H FujikiT Sugimura
Jan 1, 1977·Cold Spring Harbor Symposia on Quantitative Biology·H Cantor, E A Boyse
Jan 1, 1979·Developmental and Comparative Immunology·J LondonM Papiernik
Oct 27, 1978·Biochimica Et Biophysica Acta·M Greaves, G Janossy
Mar 1, 1979·European Journal of Immunology·A J McMichaelC Milstein
Jan 1, 1979·Immunological Reviews·D BaltimoreO N Witte
Oct 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·F J Bollum
Jan 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·G GoldsteinE A Boyse
Aug 1, 1976·The Journal of Experimental Medicine·A E SilverstoneD Baltimore
Jan 1, 1981·International Journal of Immunopharmacology·M GreavesP Kung
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J M PléauJ F Bach
Jul 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R SutherlandM Greaves
Apr 3, 1980·Nature·K F BradstockC Milstein
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·M NakayasuT Sugimura
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·A D HorowitzI B Weinstein
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·K Nagasawa, T W Mak
Jan 1, 1981·Leukemia Research·M F GreavesG Goldstein
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·E G EnglemanR Levy
Feb 6, 1981·Biochimica Et Biophysica Acta·T D ButtersP Vischer
Sep 15, 1981·International Journal of Cancer. Journal International Du Cancer·K M TveitA Pihl
Apr 1, 1981·Immunology Today·E L Reinherz, S F Schlossman

❮ Previous
Next ❯

Citations

Jul 29, 1997·International Journal of Cancer. Journal International Du Cancer·A BazJ P Bureau
Mar 1, 1993·Journal of Cellular Physiology·L M StoolmanJ Varani
May 1, 1984·Journal of Clinical Immunology·J OkamuraE W Gelfand
Jan 1, 1987·Immunology Today·M Marsh, A Dalgleish
Jan 1, 1990·International Journal of Immunopharmacology·J FaveroJ W Parker
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·B RyffelE Huberman
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·A BensussanM Sasportes
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D A CantrellM J Crumpton
Jan 25, 1988·Nucleic Acids Research·J L CaseyJ B Harford
Dec 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Magdalena LeszczynieckaPaul B Fisher
Jan 1, 1986·Cancer Investigation·L M Neckers, J B Trepel
May 1, 1992·Hematological Oncology·S KleinH Tesch
Jan 1, 1985·Critical Reviews in Oncology/hematology·R Taetle, J A Koziol
May 1, 1991·Biochemical Pharmacology·J M Backer, G L King
May 1, 1986·Experimental Cell Research·J A SchmidtH Beug
Sep 1, 1984·Regulatory Toxicology and Pharmacology : RTP·E B Siegel
Nov 1, 1986·Immunology Today·W Dröge
Oct 15, 1983·International Journal of Cancer. Journal International Du Cancer·N J de BothW van Ewijk
Jan 1, 1982·Journal of Cellular Physiology. Supplement·M F Greaves
Apr 1, 1984·Hematological Oncology·P C Beverley
Jan 1, 1988·Annals of the New York Academy of Sciences·J L CaseyJ B Harford
Dec 15, 1982·International Journal of Cancer. Journal International Du Cancer·Y NakaoY Ito
Dec 15, 1984·International Journal of Cancer. Journal International Du Cancer·F A Vyth-Dreese, J E De Vries
Jan 1, 1987·Differentiation; Research in Biological Diversity·A M Partanen, I Thesleff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.